Assignee
GENTA INC
US30 patents
Top patents by PatentIndex Score
US6060456AMay 9, 2000
Chimeric oligonucleoside compounds
GENTA INC218 citations96
US6028188AFeb 22, 2000
Synthetic oligomers having chirally pure phosphonate internucleosidyl linkages mixed with non-phosphonate internucleosidyl linkages
GENTA INC251 citations95
US6020526AFeb 1, 2000
Amide-based cationic lipids
GENTA INC73 citations95
US5877220AMar 2, 1999
Amide-based oligomeric cationic lipids
GENTA INC71 citations95
US5958901ASep 28, 1999
Phosphonic acid-based cationic lipids
GENTA INC64 citations94
US5783683AJul 21, 1998
Antisense oligonucleotides which reduce expression of the FGFRI gene
GENTA INC133 citations94
US6262036B1Jul 17, 2001
Method for inhibiting RNA translation using chimeric oligonucleoside compounds
GENTA INC41 citations92
US6005094ADec 21, 1999
Oligonucleotide analogues having improved stability at acid pH
GENTA INC44 citations92
US5854410ADec 29, 1998
Oligonucleoside cleavage compounds and therapies
GENTA INC31 citations92
US5837856ANov 17, 1998
Chirally enriched synthetic phosphonate oligomers
GENTA INC20 citations92
US5792615AAug 11, 1998
Synthetic oligomers having chirally pure phoshonate internucleosidyl linkages mixed with non-phosphonate internucleosidyl linkages
GENTA INC21 citations92
US5723599AMar 3, 1998
Organic polymer reagents for solid phase synthesis of oligonucleotides
GENTA INC22 citations92
US7060690B2Jun 13, 2006
Methods and compositions for treating a cell-proliferative disorder using CRE decoy oligomers, BCL-2 antisense oligomers, and hybrid oligomers thereof
GENTA INC17 citations91
US5789576AAug 4, 1998
Methylphosphonate dimer synthesis
GENTA INC25 citations91
US7119217B2Oct 10, 2006
Tri(alkylcarboxylato)gallium (III) products and pharmaceutical compositions containing them
GENTA INC20 citations90
US5986083ANov 16, 1999
Synthetic oligomers having phosphonate internucleosidyl linkages of undefined chirality mixed with non-phosphonate internucleosidyl linkages
GENTA INC46 citations90
US5955597ASep 21, 1999
Chirally enriched synthetic phosphate oligomers
GENTA INC19 citations89
US5616337AApr 1, 1997
Unit dose skin care package
GENTA INC120 citations89
US5936080AAug 10, 1999
Compositions and methods for the synthesis of organophosphorus derivatives
GENTA INC26 citations88
US5877160AMar 2, 1999
Compositions and methods of treatment of androgen-associated baldness using antisense oligomers
GENTA INC45 citations87
US5811538ASep 22, 1998
Process for the purification of oligomers
GENTA INC20 citations87
US5606049AFeb 25, 1997
Method of preparing 2'-O-methyl cytidine monomers useful in oligomer synthesis
GENTA INC23 citations87
US7354952B2Apr 8, 2008
Pharmaceutical gallium compositions and methods
GENTA INC11 citations83
US7456215B2Nov 25, 2008
Pharmaceutical gallium compositions and methods
GENTA INC6 citations72
US7842724B2Nov 30, 2010
Pharmaceutical gallium compositions and methods
GENTA INC3 citations61
US5726300AMar 10, 1998
Process for the synthesis of oligonucleotides and analogs with low water oxidation step
GENTA INC6 citations57
US7855183B2Dec 21, 2010
Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers
GENTA INC0 citations52
US5859234AJan 12, 1999
2'-O-methyl cytidine monomer useful in oligonucleotide synthesis
GENTA INC0 citations46
US7256284B2Aug 14, 2007
Inhibitory oligonucleotides targeted to Bcl-2
GENTA INC0 citations44
US7795232B1Sep 14, 2010
Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers
GENTA INC1 citations43